Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2022 | May 13, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Registrant Name | Altitude Acquisition Corp. | |
Entity Central Index Key | 0001822366 | |
Document Period End Date | Mar. 31, 2022 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Address, Address Line One | 400 Perimeter Center Terrace Suite 151 | |
Entity Address, City or Town | Atlanta | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, State or Province | GA | |
Entity File Number | 001-39772 | |
Entity Tax Identification Number | 85-2533565 | |
Entity Address, Postal Zip Code | 30346 | |
City Area Code | 800 | |
Local Phone Number | 950-2950 | |
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant [Member] | ||
Document Information [Line Items] | ||
Trading Symbol | ALTUU | |
Title of 12(b) Security | Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant | |
Security Exchange Name | NASDAQ | |
Common Class A [Member] | ||
Document Information [Line Items] | ||
Trading Symbol | ALTU | |
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 30,000,000 | |
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member] | ||
Document Information [Line Items] | ||
Trading Symbol | ALTUW | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share | |
Security Exchange Name | NASDAQ | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 7,500,000 |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Current Assets | ||
Cash | $ 22,971 | $ 43,054 |
Prepaid expenses | 145,233 | 187,288 |
Total current assets | 168,204 | 230,342 |
Investments held in Trust Account | 300,034,396 | 300,026,796 |
Total assets | 300,202,600 | 300,257,138 |
Current Liabilities | ||
Accounts payable | 150,862 | 174,803 |
Advances from Sponsor | 450,000 | 100,000 |
Due to related party | 152,089 | 122,089 |
Total current liabilities | 752,951 | 396,892 |
Warrant liability | 3,911,475 | 13,449,283 |
Deferred legal fee | 4,243,758 | 3,733,738 |
Deferred underwriting fee | 10,500,000 | 10,500,000 |
Total liabilities | 19,408,184 | 28,079,913 |
Commitments and Contingencies | ||
Class A common stock subject to possible redemption, $0.0001 par value, 30,000,000 shares subject to possible redemption at redemption value of $10.00 per share at March 31, 2022 and December 31, 2021 | 300,000,000 | 300,000,000 |
Stockholders' deficit: | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding at March 31, 2022 and December 31, 2021 | ||
Additional paid-in capital | ||
Accumulated deficit | (19,206,334) | (27,823,525) |
Total stockholders's deficit | (19,205,584) | (27,822,775) |
Total liabilities, Class A common stock subject to possible redemption and stockholders' deficit | 300,202,600 | 300,257,138 |
Common Class A [Member] | ||
Current Liabilities | ||
Class A common stock subject to possible redemption, $0.0001 par value, 30,000,000 shares subject to possible redemption at redemption value of $10.00 per share at March 31, 2022 and December 31, 2021 | 300,000,000 | 300,000,000 |
Stockholders' deficit: | ||
Common stock value | ||
Common Class B [Member] | ||
Stockholders' deficit: | ||
Common stock value | $ 750 | $ 750 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2022 | Dec. 31, 2021 |
Preferred stock shares authorized | 1,000,000 | 1,000,000 |
Preferred stock par value | $ 0.0001 | $ 0.0001 |
Preferred stock shares issued | 0 | 0 |
Preferred stock shares outstanding | 0 | 0 |
Common Class A [Member] | ||
Temporary equity shares par value | $ 0.0001 | $ 0.0001 |
Temporary equity shares outstanding | 30,000,000 | 30,000,000 |
Common stock par value | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 280,000,000 | 280,000,000 |
Common stock shares issued | 0 | 0 |
Common stock shares outstanding | 0 | 0 |
Temporary equity redemption price per share | $ 10 | $ 10 |
Common Class B [Member] | ||
Common stock par value | $ 0.0001 | $ 0.0001 |
Common stock shares authorized | 20,000,000 | 20,000,000 |
Common stock shares issued | 7,500,000 | 7,500,000 |
Common stock shares outstanding | 7,500,000 | 7,500,000 |
Condensed Statements of Operati
Condensed Statements of Operations - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Formation and operating costs | $ 928,218 | $ 466,358 |
Loss from operations | (928,218) | (466,358) |
Other income (loss) | ||
Interest Income | 1 | 12 |
Interest income earned on Trust | 7,600 | 6,247 |
Unrealized gain (loss) on change in fair value of warrants | 9,537,808 | (5,996,188) |
Total other income (loss) | 9,545,409 | (5,989,929) |
Net income (loss) | 8,617,191 | (6,456,287) |
Common Class A [Member] | ||
Other income (loss) | ||
Net income (loss) | $ 6,893,753 | $ (5,165,030) |
Basic and diluted weighted average shares outstanding | 30,000,000 | 30,000,000 |
Basic and diluted net income per share | $ 0.23 | $ (0.17) |
Common Class B [Member] | ||
Other income (loss) | ||
Net income (loss) | $ 1,723,438 | $ (1,291,257) |
Basic and diluted weighted average shares outstanding | 7,500,000 | 7,500,000 |
Basic and diluted net income per share | $ 0.23 | $ (0.17) |
Condensed Statements of Changes
Condensed Statements of Changes in Stockholders' Deficit - USD ($) | Total | Common Class A [Member] | Common Class B [Member] | Common Stock [Member]Common Class A [Member] | Common Stock [Member]Common Class B [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] |
Beginning balance at Dec. 31, 2020 | $ (43,048,604) | $ 0 | $ 750 | $ 0 | $ (43,049,354) | ||
Beginning balance (in shares) at Dec. 31, 2020 | 0 | 7,500,000 | |||||
Net income | (6,456,287) | $ (5,165,030) | $ (1,291,257) | (6,456,287) | |||
Ending balance at Mar. 31, 2021 | (49,504,891) | $ 0 | $ 750 | 0 | (49,505,641) | ||
Ending balance (in shares) at Mar. 31, 2021 | 0 | 7,500,000 | |||||
Beginning balance at Dec. 31, 2021 | (27,822,775) | $ 0 | $ 750 | 0 | (27,823,525) | ||
Beginning balance (in shares) at Dec. 31, 2021 | 0 | 7,500,000 | |||||
Net income | 8,617,191 | $ 6,893,753 | $ 1,723,438 | 8,617,191 | |||
Ending balance at Mar. 31, 2022 | $ (19,205,584) | $ 0 | $ 750 | $ 0 | $ (19,206,334) | ||
Ending balance (in shares) at Mar. 31, 2022 | 0 | 7,500,000 |
Statement of Cash Flows
Statement of Cash Flows - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Cash Flows from Operating Activities: | ||
Net income (loss) | $ 8,617,191 | $ (6,456,287) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Interest income earned on Trust | (7,600) | (6,247) |
Unrealized (gain)/loss on change in fair value of warrants | (9,537,808) | 5,996,188 |
Changes in current assets and current liabilities: | ||
Prepaid expenses | 42,055 | 99,151 |
Due to related party | 30,000 | 29,204 |
Deferred legal fee | 510,020 | 0 |
Advances from Sponsor | 350,000 | 0 |
Accounts payable and accrued expenses | (23,941) | (12,943) |
Net cash used in operating activities | (20,083) | (350,934) |
Net Change in Cash | (20,083) | (350,934) |
Cash—Beginning | 43,054 | 764,329 |
Cash—Ending | $ 22,971 | $ 413,395 |
Organization and Business Opera
Organization and Business Operations | 3 Months Ended |
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and business operations | Note 1 - Organization and Business Operations Altitude Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated in Delaware on August 12, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). As of March 31, 2022, the Company had not commenced any operations. All activity for the period from August 12, 2020 (inception) through March 31, 2022 relates to the Company’s formation and the initial public offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating Financing The Company’s sponsor is Altitude Acquisition Holdco LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO (as described below) was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on December 8, 2020 (the “Effective Date”). On December 11, 2020, the Company consummated the IPO of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), including the issuance of 3,900,000 Units as a result of the partial exercise of the underwriters’ over-allotment option, at $10.00 per Unit generating gross proceeds of $300,000,000, which is described in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of an aggregate of 8,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per warrant in a private placement to the Company’s Sponsor, generating gross proceeds to the Company of $8,000,000, which is described in Note 4. Trust Account Following the closing of the IPO on December 11, 2020, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account established for the benefit of the Company’s public stockholders (the “Trust Account”) which was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 Initial Business Combination The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The shares of common stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with an initial Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of an initial Business Combination and, if the Company seeks stockholder approval, such initial Business Combination is approved by the affirmative vote of the holders of a majority of the shares of the Common Stock that are voted at a stockholder meeting held to consider such initial Business Combination. The Company has until June 11, 2022 to consummate a Business Combination. However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate. The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period. Going Concern Consideration As of March 31, 2022, the Company had cash outside the Trust Account of $22,971 available for working capital needs, and a negative working capital of $584,747. Prior to the completion of the IPO, the Company’s liquidity needs had been satisfied through a payment from the Sponsor of $25,000 for the founder shares, the loan under an unsecured promissory note from the Sponsor of $275,000, and advances from the Sponsor of $634,447. Subsequent to the consummation of the IPO and Private Placement, the Company’s liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with an initial Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). To date, there were no amounts outstanding under any Working Capital Loans. On June 2, 2021, the Company issued an unsecured promissory note to the Sponsor for an aggregate available principal amount of $300,000 to be used for a portion of the expenses of the Business Combination. This loan is non-interest bearing, On November 16, 2021, January 18, 2022 and February 1, 2022, the Company received $100,000, $100,000 and $250,000 advances from the Sponsor to be used for working capital purposes, respectively. The advances are non-interest bearing and due on demand. At March 31, 2022 and December 31, 2021, the Company owed the Sponsor $450,000 and $100,000 related to these advances, respectively. The Company has until June 11, 2022 to consummate a Business Combination. If the Company is unable to complete a Business Combination prior to June 11, 2022, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate. As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 2 - Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future periods. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Form 10-K Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, the Company did not have any cash equivalents. Investments held in Trust Account As of March 31, 2022 and December 31, 2021, the assets held in the Trust Account were substantially held in mutual funds comprised of U.S. Treasury Bills. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 30,000,000 shares of Class A common stock subject to possible redemption were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. Net Income (loss) Per Common Stock The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. For the three months For the three months ended March 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per share: Numerator: Allocation of net income (loss) $ 6,893,753 $ 1,723,438 $ (5,165,030 ) $ (1,291,257 ) Denominator: Weighted-average shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income (loss) per share $ 0.23 $ 0. 2 $ (0.17 ) $ (0.17 ) Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Private Placement Warrants is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Private Placement Warrants is classified as Level 3. The fair value of the Public Warrants is classified as Level 1. See Note 6 for additional information on assets and liabilities measured at fair value. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at current or non-current based or not net-cash settlement FASB ASC 470-20, Debt Income Taxes The Company accounts for income taxes under ASC 740 “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. There are deferred taxes with a full valuation allowance at March 31, 2022 and December 31, 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and each country’s potential response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential target technology companies in the northern part of Europe, where we intend to focus our search. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on the Company’s ability to complete a Business Combination with a suitable target. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2022 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 3 - Initial Public Offering On December 11, 2020, the Company sold 30,000,000 Units, including 3,900,000 Units issued pursuant to the underwriters’ partial exercise of their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, and one-half The Company paid an underwriting fee at the closing of the IPO of $6,000,000. As of March 31, 2022 and December 31, 2021, an additional fee of $10,500,000 (see Note 7) was deferred and will become payable upon the Company’s completion of an initial Business Combination. The deferred portion of the fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination. All of the 30,000,000 Class A common stock sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, The Class A common stock is recorded in accordance with in ASC 480-10-S99. paid-in As of March 31, 2022 and December 31, 2021, the common stock reflected on the condensed balance sheets are reconciled in the following table: Gross proceeds from IPO $ 300,000,000 Less: Proceeds allocated to Public Warrants (19,987,400 ) Common stock issuance costs (15,968,970 ) Plus: Accretion of carrying value to redemption value 35,956,370 Class A common stock subject to possible redemption $ 300,000,000 Warrants Each whole warrant will entitle the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any Founder Shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable on the later of twelve months from the closing of the IPO or thirty days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit. Once the warrants become exercisable, the Company may call the warrants for redemption: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption (the “30-day • if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A common stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2022 | |
Warrants and Rights Note Disclosure [Abstract] | |
Private Placement | Note 4 - Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 8,000,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8,000,000. The proceeds from the sale of the Private Placement Warrants were added to the proceeds from the IPO held in the Trust Account. The Private Placement Warrants are identical to the warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, and (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting fees were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 5 - Related Party Transactions Founder Shares In August 2020, the Company issued 8,625,000 shares of Class B common stock to the Sponsor for $25,000 in cash, or approximately $0.003 per share (the “Founder Shares”). On November 30, 2020 the Sponsor surrendered an aggregate of 1,437,500 Founder Shares, which were cancelled. On December 8, 2020, as part of an upsizing of the IPO, the Company effected a stock split in which each issued share of Class B common stock that was outstanding was converted into one and forty-four one-thousandths shares of The Sponsor has agreed not to transfer, assign or sell its Founder Shares until the earlier to occur of (A) one year any 20 trading days within any 30-trading day period commencing Promissory Note - Related Party On August 12, 2020, the Company issued an unsecured promissory note to the Sponsor for an aggregate available principal amount of $300,000 to be used for a portion of the expenses of the IPO. This loan is non-interest bearing, unsecured and due On June 2, 2021, the Company issued an unsecured promissory note to the Sponsor for an aggregate available principal amount of $300,000 to be used for a portion of the expenses of the Business Combination. This loan is non-interest bearing, as of March 31, 2022 and D ecember 31, 2021. Due to Related Party As of March 31, 2022 and December 31, 2021, the Company had due to related party balance s Advances from Sponsor On December 11, 2020, the Sponsor advanced the Company an aggregate of $634,447. The Company repaid the amount in full on December 16, 2020. On November 16, 2021, January 18, 2022 and February 1, 2022, the Company received $100,000, $100,000 and $ , respectively. non-interest Working Capital Loans In order to finance transaction costs in connection with an initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes an initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. At March 31, 2022 and December 31, 2021, no Working Capital Loans were outstanding. Administrative Service Fee The Company has agreed, commencing on the date of the securities of the Company are first listed on The Nasdaq Capital Market, to pay an affiliate of the Company’s Sponsor a monthly fee of an aggregate of $10,000 for office space, utilities and secretarial and administrative support. Upon completion of the Company’s initial Business Combination or its liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 and $37,667 s , respectively. |
Recurring Fair Value Measuremen
Recurring Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Recurring Fair Value Measurements | Note 6 - Recurring Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, 2022 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Money Market Funds held in Trust Account $ 300,034,396 $ 300,034,396 $ — $ — $ 300,034,396 $ 300,034,396 $ — $ — Liabilities: Warrant Liability - Public Warrants $ 2,517,000 $ 2,517,000 $ — $ — Warrant Liability - Private Placement Warrants $ 1,394,475 $ — $ — $ 1,394,475 $ 3,911,475 $ 2,517,000 $ — $ 1,394,475 The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2021 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. December 31, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Money Market Funds held in Trust Account $ 300,026,796 $ 300,026,796 $ — $ — $ 300,026,796 $ 300,026,796 $ — $ — Liabilities: Warrant Liability - Public Warrants $ 8,626,500 $ 8,626,500 $ — $ — Warrant Liability - Private Placement Warrants $ 4,822,783 $ — $ — $ 4,822,783 $ 13,449,283 $ 8,626,500 $ — $ 4,822,783 The measurement of the Public Warrants at March 31, 2022 and December 31, 2021 is classified as Level 1 due to the use of an observable market quote in an active market. As of March 31, 2022 and December 31, 2021, the aggregate value of Public Warrants was $2,517,000 and $8,626,500, respectively. The estimated fair value of the Private Placement Warrants on March 31, 2022 and December 31, 2021 is determined using Level 3 inputs. Inherent in a Monte Carlo simulation model are assumptions related to expected stock-price volatility (pre-merger and post-merger), The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at March 31, 2022: Input March 31, 2022 Expected term (years) 5.13 Expected volatility 3.2 % Risk-free interest rate 2.42 % Fair value of the common stock price $ 9.95 The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at December 31, 2021: Input December 31, 2021 Expected term (years) 5.37 Expected volatility 12.4 % Risk-free interest rate 1.29 % Fair value of the common stock price $ 9.90 The primary significant unobservable input used in the fair value measurement of the Company’s Private Placement Warrants is the expected volatility of the common stock. Significant increases (decreases) in the expected volatility in isolation would result in a significantly higher (lower) fair value measurement. The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three months ended March 31, 2022: Warrant Liability Fair value as of December 31, 2021 $ 4,822,783 Change in fair value (3,428,308 ) Fair value as of March 31, 2022 $ 1,394,475 The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three months ended March 31, 2021: Warrant Liability Fair value as of December 31, 2020 $ 33,807,463 Transfer out of Level 3 to Level 1 (25,500,000 ) Change in fair value 5,996,188 Fair value as of March 31, 2021 $ 14,303,651 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 7 - Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement signed prior to or on the Effective Date. These holders are entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders are entitled to “piggy-back” registration rights. Underwriting Agreement The underwriters had a 45-day option from December 11, 2020 On December 11, 2020, the underwriters were paid a cash underwriting fee of $6,000,000, or 2% of the gross proceeds of the IPO. Additionally, the underwriters will be entitled to a deferred underwriting fee of $10,500,000, or 3.5% of the gross proceeds of the IPO held in the Trust Account upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement. |
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) | 3 Months Ended |
Mar. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity (Deficit) | Note 8 - Stockholders’ Equity (Deficit) Preferred Stock The Company is authorized to issue a total of 1,000,000 0.0001 Class A Common Stock The Company is authorized to issue a total of 280,000,000 shares of Class A common stock at par value of $0.0001 each. As of March 31, 2022 and December 31, 2021, there were there were no shares of Class A common stock issued and outstanding, excluding 30,000,000 shares of Class A common stock subject to redemption, which are included in temporary equity. Class B Common Stock The Company is authorized to issue a total of 20,000,000 shares of Class B common stock at par value of $0.0001 each. After giving retroactive effect to the forfeiture of shares and subsequent split described in Note 5, there were 7,503,750 shares of Class B common stock issued and outstanding at December 11, 2020. The Founder Shares included an aggregate of up to 978,750 shares subject to forfeiture if the over-allotment option was not exercised by the underwriters in full. On December 11, 2020, the underwriters partially exercised their over-allotment option, hence, 975,000 Founder Shares were no longer subject to forfeiture and 3,750 Founder Shares were forfeited for no consideration. As of March 31, 2022 and December 31, 2021, there were 7,500,000 shares of Class B common stock issued and outstanding. The Company’s initial stockholders have agreed not to transfer, assign or sell its Founder Shares until the earlier to occur of (A) one year any 30-trading day The shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of its initial Business Combination on a one-for-one in the aggregate, on an as-converted basis, 20% of Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, with each share of common stock entitling the holder to one vote. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 9 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet dates, up to the date on which the condensed financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. On April 26, 2022 and May 2, 2022, the Company received $50,000 and $100,000 advances from the Sponsor to be used for working capital purposes, respectively. The advances are non-interest bearing and due on demand. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future periods. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Form 10-K |
Emerging Growth Company Status | Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging |
Use of Estimates | Use of Estimates The preparation of these condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of these condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, the Company did not have any cash equivalents. |
Investments held in Trust Account | Investments held in Trust Account As of March 31, 2022 and December 31, 2021, the assets held in the Trust Account were substantially held in mutual funds comprised of U.S. Treasury Bills. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 30,000,000 shares of Class A common stock subject to possible redemption were presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. |
Net Income (loss) Per Common Stock | Net Income (loss) Per Common Stock The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. For the three months For the three months ended March 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per share: Numerator: Allocation of net income (loss) $ 6,893,753 $ 1,723,438 $ (5,165,030 ) $ (1,291,257 ) Denominator: Weighted-average shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income (loss) per share $ 0.23 $ 0. 2 $ (0.17 ) $ (0.17 ) |
Offering Costs | Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Private Placement Warrants is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Private Placement Warrants is classified as Level 3. The fair value of the Public Warrants is classified as Level 1. See Note 6 for additional information on assets and liabilities measured at fair value. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at current or non-current based or not net-cash settlement FASB ASC 470-20, Debt |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740 “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. There are deferred taxes with a full valuation allowance at March 31, 2022 and December 31, 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Recent Accounting Standards | Recent Accounting Standards Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
Risks and Uncertainties | Risks and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the U.S. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and each country’s potential response to such sanctions, tensions, and military actions could have a material adverse effect on the business or prospects of potential target technology companies in the northern part of Europe, where we intend to focus our search. Any such material adverse effect from the conflict and enhanced sanctions activity may include reduced trading and business activity levels, disruption of financial markets, increased costs, disruption of services, inability to complete financial or banking transactions, and inability to service existing or new customers in the region. Prolonged unrest, military activities, or broad-based sanctions, should they be implemented, could have a material adverse effect on the Company’s ability to complete a Business Combination with a suitable target. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Net Loss Per of Common Stock Basic and Diluted | The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock. For the three months For the three months ended March 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per share: Numerator: Allocation of net income (loss) $ 6,893,753 $ 1,723,438 $ (5,165,030 ) $ (1,291,257 ) Denominator: Weighted-average shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income (loss) per share $ 0.23 $ 0. 2 $ (0.17 ) $ (0.17 ) |
Initial Public Offering (Tables
Initial Public Offering (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Temporary Equity Disclosure [Abstract] | |
Summary of Class A common stock subject to redemption | As of March 31, 2022 and December 31, 2021, the common stock reflected on the condensed balance sheets are reconciled in the following table: Gross proceeds from IPO $ 300,000,000 Less: Proceeds allocated to Public Warrants (19,987,400 ) Common stock issuance costs (15,968,970 ) Plus: Accretion of carrying value to redemption value 35,956,370 Class A common stock subject to possible redemption $ 300,000,000 |
Recurring Fair Value Measurem_2
Recurring Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Assets And Liabilities Measured At Fair Value | The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, 2022 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Money Market Funds held in Trust Account $ 300,034,396 $ 300,034,396 $ — $ — $ 300,034,396 $ 300,034,396 $ — $ — Liabilities: Warrant Liability - Public Warrants $ 2,517,000 $ 2,517,000 $ — $ — Warrant Liability - Private Placement Warrants $ 1,394,475 $ — $ — $ 1,394,475 $ 3,911,475 $ 2,517,000 $ — $ 1,394,475 The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2021 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. December 31, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Money Market Funds held in Trust Account $ 300,026,796 $ 300,026,796 $ — $ — $ 300,026,796 $ 300,026,796 $ — $ — Liabilities: Warrant Liability - Public Warrants $ 8,626,500 $ 8,626,500 $ — $ — Warrant Liability - Private Placement Warrants $ 4,822,783 $ — $ — $ 4,822,783 $ 13,449,283 $ 8,626,500 $ — $ 4,822,783 |
Summary of the Monte Carlo simulation model for the Private Placement Warrants | The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at March 31, 2022: Input March 31, 2022 Expected term (years) 5.13 Expected volatility 3.2 % Risk-free interest rate 2.42 % Fair value of the common stock price $ 9.95 The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at December 31, 2021: Input December 31, 2021 Expected term (years) 5.37 Expected volatility 12.4 % Risk-free interest rate 1.29 % Fair value of the common stock price $ 9.90 |
Summary of the changes in the fair value of the Level 3 warrant liability | The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three months ended March 31, 2022: Warrant Liability Fair value as of December 31, 2021 $ 4,822,783 Change in fair value (3,428,308 ) Fair value as of March 31, 2022 $ 1,394,475 The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three months ended March 31, 2021: Warrant Liability Fair value as of December 31, 2020 $ 33,807,463 Transfer out of Level 3 to Level 1 (25,500,000 ) Change in fair value 5,996,188 Fair value as of March 31, 2021 $ 14,303,651 |
Organization and Business Ope_2
Organization and Business Operations - Additional Information (Detail) | Jun. 11, 2022 | Feb. 01, 2022USD ($) | Jan. 18, 2022USD ($) | Dec. 16, 2021USD ($) | Nov. 16, 2021USD ($) | Dec. 11, 2020USD ($)$ / sharesshares | Mar. 31, 2022USD ($)$ / sharesshares | Mar. 31, 2021USD ($) | Dec. 31, 2021USD ($) | Jun. 02, 2021USD ($) | Aug. 12, 2020USD ($) |
Organization And Business Operations [Line Items] | |||||||||||
Date of incorporation | Aug. 12, 2020 | ||||||||||
Entity incorporation date or country code | DE | ||||||||||
Payment to acquire restricted investments | $ 300,000,000 | ||||||||||
Per share value of restricted investments | $ / shares | $ 10 | ||||||||||
Term of restricted investments | 185 days | ||||||||||
Temporary equity redemption price per share | $ / shares | $ 10 | ||||||||||
Minimum net worth to effect business combination | $ 5,000,001 | ||||||||||
Percentage of public shares due for redemption | 100.00% | ||||||||||
Minimum per share amount to be maintained in the trust account | $ / shares | $ 10 | ||||||||||
Cash | $ 22,971 | ||||||||||
Net current assets | 584,747 | ||||||||||
Stock issued during the value for services value | $ 25,000 | ||||||||||
Advances from Sponsor | 350,000 | $ 0 | |||||||||
Percentage of outstanding public shares | 100 | ||||||||||
Sponsor [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Advances from Sponsor | $ 250,000 | $ 100,000 | $ 100,000 | ||||||||
Due To Related Parties Current | $ 450,000 | $ 100,000 | |||||||||
Promissory Note Related Party [Member] | Sponsor [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Proceeds from related party debt | $ 275,000 | 275,000 | |||||||||
Debt instrument face value | $ 300,000 | $ 300,000 | |||||||||
Due To Related Party [Member] | Sponsor [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Proceeds from related party debt | $ 634,447 | $ 634,447 | |||||||||
Minimum [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Minimum per share amount to be maintained in the trust account | $ / shares | $ 10 | ||||||||||
Private Placement Warrants [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Class of warrants or rights issued during the period warrants | shares | 8,000,000 | ||||||||||
Class of warrants or rights issued price per warrant | $ / shares | $ 1 | ||||||||||
Proceeds from the issuance of warrants | $ 8,000,000 | ||||||||||
IPO [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Stock issued during the period shares | shares | 30,000,000 | ||||||||||
Proceeds from initial public offering | 300,000,000 | 300,000,000 | |||||||||
Proceeds from the issuance of warrants | $ 19,987,400 | $ 19,987,400 | |||||||||
Over-Allotment Option [Member] | |||||||||||
Organization And Business Operations [Line Items] | |||||||||||
Stock issued during the period shares | shares | 3,900,000 | ||||||||||
Sale of stock issue price per share | $ / shares | $ 10 | ||||||||||
Proceeds from initial public offering | $ 300,000,000 |
Significant Accounting Polici_4
Significant Accounting Policies - Additional Information (Detail) - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Accounting Policies [Line Items] | ||
Cash equivalents | $ 0 | $ 0 |
Number of Common stock into which the class of warrant or right may be converted | 23,000,000 | |
Common Class A [Member] | ||
Accounting Policies [Line Items] | ||
Temporary equity shares outstanding | 30,000,000 | 30,000,000 |
Minimum [Member] | ||
Accounting Policies [Line Items] | ||
Cash with federal depository insurance corporation | $ 250,000 |
Significant Accounting Polici_5
Significant Accounting Policies - Summary of Net Loss Per of Common Stock Basic and Diluted (Detail) - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Numerator: | ||
Allocation of net income (loss) | $ 8,617,191 | $ (6,456,287) |
Common Class A [Member] | ||
Numerator: | ||
Allocation of net income (loss) | $ 6,893,753 | $ (5,165,030) |
Denominator: | ||
Weighted-average shares outstanding | 30,000,000 | 30,000,000 |
Basic and diluted net loss per share | $ 0.23 | $ (0.17) |
Common Class B [Member] | ||
Numerator: | ||
Allocation of net income (loss) | $ 1,723,438 | $ (1,291,257) |
Denominator: | ||
Weighted-average shares outstanding | 7,500,000 | 7,500,000 |
Basic and diluted net loss per share | $ 0.23 | $ (0.17) |
Initial Public Offering - Addit
Initial Public Offering - Additional Information (Detail) - USD ($) | Dec. 11, 2020 | Mar. 31, 2022 | Dec. 31, 2021 |
Class of Stock [Line Items] | |||
Class of warrants or rights number of shares called for by each warrant or right | 1 | ||
Class of warrants or rights exercise price | $ 11.50 | ||
Class of warrants or rights term | 5 years | ||
Payment of stock issuance costs | $ 6,000,000 | ||
Deferred underwriting fee | $ 10,500,000 | $ 10,500,000 | |
Prospective Warrant Redemption [Member] | |||
Class of Stock [Line Items] | |||
Proceeds from business combination as a total percentage of capital raised | 60.00% | ||
Prospective Warrant Redemption [Member] | Trigger Price One [Member] | Common Class A [Member] | |||
Class of Stock [Line Items] | |||
Sale of stock issue price per share | $ 9.20 | ||
Number of consecutive trading day period for determining volume weighted average price | 20 days | ||
Percentage of the newly issued share price | 115.00% | ||
Prospective Warrant Redemption [Member] | Trigger Price Two [Member] | Common Class A [Member] | |||
Class of Stock [Line Items] | |||
Sale of stock issue price per share | $ 18 | ||
Percentage of the newly issued share price | 180.00% | ||
Number of trading days for determining share price | 20 days | ||
Aggregate number of trading days for determining the share price | 30 days | ||
Class of warrants or rights redemption price per warrant | $ 0.01 | ||
Minimum days of notice to be given prior to redemption | 30 days | ||
After The Completion Of Business Combination [Member] | |||
Class of Stock [Line Items] | |||
Period after which the warrants are exercisable | 30 days | ||
After The Closing Of Initial Public Offer [Member] | |||
Class of Stock [Line Items] | |||
Period after which the warrants are exercisable | 12 months | ||
IPO [Member] | |||
Class of Stock [Line Items] | |||
Stock issued during the period shares | 30,000,000 | ||
Deferred underwriting fee | $ 10,500,000 | ||
Over-Allotment Option [Member] | |||
Class of Stock [Line Items] | |||
Stock issued during the period shares | 3,900,000 | ||
Sale of stock issue price per share | $ 10 |
Initial Public Offering - Summa
Initial Public Offering - Summary of Class A common stock subject to redemption (Detail) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Plus: | ||
Class A common stock subject to possible redemption | $ 300,000,000 | $ 300,000,000 |
Common Class A [Member] | ||
Less: | ||
Common stock issuance costs | (15,968,970) | (15,968,970) |
Plus: | ||
Accretion of carrying value to redemption value | 35,956,370 | 35,956,370 |
Class A common stock subject to possible redemption | 300,000,000 | 300,000,000 |
IPO [Member] | ||
Temporary Equity [Line Items] | ||
Gross proceeds from IPO | 300,000,000 | 300,000,000 |
Less: | ||
Proceeds allocated to Public Warrants | $ (19,987,400) | $ (19,987,400) |
Private Placement - Additional
Private Placement - Additional Information (Detail) - Private Placement Warrants [Member] | 3 Months Ended |
Mar. 31, 2022USD ($)$ / sharesshares | |
Subsidiary or Equity Method Investee [Line Items] | |
Class of warrants or rights issued during the period warrants | shares | 8,000,000 |
Class of warrants or rights issued price per warrant | $ / shares | $ 1 |
Proceeds from the issuance of warrants | $ | $ 8,000,000 |
Class of warrants or rights lock in period after business combination | 30 days |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) | Feb. 01, 2022 | Jan. 18, 2022 | Dec. 16, 2021 | Nov. 16, 2021 | Dec. 11, 2020 | Nov. 30, 2020 | Aug. 31, 2020 | Mar. 31, 2022 | Mar. 31, 2021 | Dec. 31, 2021 | Jun. 02, 2021 | Aug. 12, 2020 |
Related Party Transaction [Line Items] | ||||||||||||
Advances from Sponsor | $ 350,000 | $ 0 | ||||||||||
Notes Payable, Related Parties, Current | 450,000 | $ 100,000 | ||||||||||
Accounts payable related party current | 152,089 | 122,089 | ||||||||||
Over-Allotment Option [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Stock issued during the period shares | 3,900,000 | |||||||||||
Sale of stock issue price per share | $ 10 | |||||||||||
Due To Related Party [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Accounts payable receivable from related party current | 152,089 | 122,089 | ||||||||||
Accounts receivable from related party current | 5,578 | 5,578 | ||||||||||
Accounts payable related party current | 157,667 | 127,667 | ||||||||||
Advances From Related Party [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Due To Related Parties Current | $ 450,000 | 100,000 | ||||||||||
Advances from Sponsor | $ 250,000 | $ 100,000 | $ 100,000 | |||||||||
Sponsor [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Lock in period of shares | 1 year | |||||||||||
Share price | $ 12 | |||||||||||
Number of trading days for determining the share price | 20 days | |||||||||||
Number of consecutive trading days for determining the share price | 30 days | |||||||||||
Waiting time after which the share price is considered | 150 days | |||||||||||
Fee payable for month for secretarial administrative and support services | $ 10,000 | |||||||||||
Related party transaction administrative service fees incurred but not paid | 30,000 | $ 37,667 | ||||||||||
Due To Related Parties Current | 450,000 | 100,000 | ||||||||||
Advances from Sponsor | $ 250,000 | $ 100,000 | 100,000 | |||||||||
Accounts payable related party current | 157,667 | |||||||||||
Sponsor [Member] | Promissory Note Related Party [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Debt instrument face value | $ 300,000 | $ 300,000 | ||||||||||
Proceeds from related party debt | $ 275,000 | $ 275,000 | ||||||||||
Repayment of related party debt | $ 275,000 | |||||||||||
Notes Payable, Related Parties, Current | 0 | 0 | ||||||||||
Sponsor [Member] | Due To Related Party [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Proceeds from related party debt | $ 634,447 | $ 634,447 | ||||||||||
Sponsor [Member] | Working Capital Loans [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Working capital loans convertible into equity warrants value | $ 1,500,000 | |||||||||||
Debt instrument convertible price per share | $ 1 | |||||||||||
Working capital loan outstanding | $ 0 | $ 0 | ||||||||||
Common Class B [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Common stock shares issued | 7,503,750 | 7,500,000 | 7,500,000 | |||||||||
Common stock shares outstanding | 7,500,000 | 7,500,000 | ||||||||||
Common Class B [Member] | Over-Allotment Option [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Founders shares included aggregate subject to forfeiture | 978,750 | |||||||||||
Underwriters partially exercised subject to forfeiture | 975,000 | |||||||||||
Common Class B [Member] | Proposed Public Offering [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Common stock shares issued | 7,503,750 | |||||||||||
Common stock shares outstanding | 7,503,750 | 7,503,750 | ||||||||||
Common Class B [Member] | Sponsor [Member] | ||||||||||||
Related Party Transaction [Line Items] | ||||||||||||
Stock issued during the period shares | 8,625,000 | |||||||||||
Stock issued during the period value | $ 25,000 | |||||||||||
Sale of stock issue price per share | $ 0.003 | |||||||||||
Share based compensation by share based payment arrangement shares forfeited | 3,750 | |||||||||||
Founders shares aggregate surrendered were cancelled | 1,437,500 |
Recurring Fair Value Measurem_3
Recurring Fair Value Measurements - Summary of Assets And Liabilities Measured At Fair Value (Detail) - Fair Value, Recurring [Member] - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | $ 300,034,396 | $ 300,026,796 |
Liabilities | 3,911,475 | 13,449,283 |
Public Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 2,517,000 | 8,626,500 |
Private Placement Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 1,394,475 | 4,822,783 |
Quoted Prices In Active Markets (Level 1) [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 300,034,396 | 300,026,796 |
Liabilities | 2,517,000 | 8,626,500 |
Quoted Prices In Active Markets (Level 1) [Member] | Public Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 2,517,000 | 8,626,500 |
Significant Other Unobservable Inputs (Level 3) [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 1,394,475 | 4,822,783 |
Significant Other Unobservable Inputs (Level 3) [Member] | Private Placement Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liabilities | 1,394,475 | 4,822,783 |
Money Market Funds held in Trust Account [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | 300,034,396 | 300,026,796 |
Money Market Funds held in Trust Account [Member] | Quoted Prices In Active Markets (Level 1) [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets | $ 300,034,396 | $ 300,026,796 |
Recurring Fair Value Measurem_4
Recurring Fair Value Measurements - Summary of the Monte Carlo simulation model for the Private Placement Warrants (Detail) - Warrant Liability [Member] - Private Placement Warrants [Member] - Fair Value, Inputs, Level 3 [Member] - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2022 | Dec. 31, 2021 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Expected term (years) | 5 years 1 month 17 days | 5 years 4 months 13 days |
Expected volatility | 3.20% | 12.40% |
Risk-free interest rate | 2.42% | 1.29% |
Fair value of the common stock price | $ 9.95 | $ 9.90 |
Recurring Fair Value Measurem_5
Recurring Fair Value Measurements - Summary of the changes in the fair value of the Level 3 warrant liability (Detail) - Private Placement Warrants [Member] - Warrant Liability [Member] - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Beginning balance | $ 4,822,783 | $ 33,807,463 |
Transfer out of Level 3 to Level 1 | (25,500,000) | |
Change in fair value | (3,428,308) | 5,996,188 |
Ending balance | $ 1,394,475 | $ 14,303,651 |
Recurring Fair Value Measurem_6
Recurring Fair Value Measurements - Additional information (Detail) - Fair Value, Recurring [Member] - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Aggregate fair value of public warrants | $ 3,911,475 | $ 13,449,283 |
Public Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Aggregate fair value of public warrants | 2,517,000 | 8,626,500 |
Public Warrants [Member] | Warrant Liability [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Aggregate fair value of public warrants | $ 2,517,000 | $ 8,626,500 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | Dec. 11, 2020 | Mar. 31, 2022 | Dec. 31, 2021 |
Other Commitments [Line Items] | |||
Payment of stock issuance costs | $ 6,000,000 | ||
Deferred underwriting fee | $ 10,500,000 | $ 10,500,000 | |
Over-Allotment Option [Member] | |||
Other Commitments [Line Items] | |||
Number of days given to underwriters to subscribe to over allotment option | 45 days | ||
Common stock shares subscribed but not issued | 3,915,000 | ||
Stock issued during the period shares | 3,900,000 | ||
IPO [Member] | |||
Other Commitments [Line Items] | |||
Stock issued during the period shares | 30,000,000 | ||
Deferred underwriting commission as a percentage of gross proceeds of initial public offer | 2.00% | ||
Deferred underwriting fee | $ 10,500,000 | ||
Deferred underwriting commission payable as a percentage of gross proceeds of initial public offer | 3.50% |
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) - Additional Information (Detail) - $ / shares | Dec. 11, 2020 | Mar. 31, 2022 | Dec. 31, 2021 |
Class of Stock [Line Items] | |||
Preferred stock shares authorized | 1,000,000 | 1,000,000 | |
Preferred stock shares par or stated value per share | $ 0.0001 | $ 0.0001 | |
Preferred stock shares issued | 0 | 0 | |
Preferred stock shares outstanding | 0 | 0 | |
Sponsor [Member] | |||
Class of Stock [Line Items] | |||
Lock in period of shares | 1 year | ||
Share price | $ 12 | ||
Number of trading days for determining the share price | 20 days | ||
Number of consecutive trading days for determining the share price | 30 days | ||
Waiting time after which the share price is considered | 150 days | ||
Common Class A [Member] | |||
Class of Stock [Line Items] | |||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock shares authorized | 280,000,000 | 280,000,000 | |
Common stock shares issued | 0 | 0 | |
Common stock shares outstanding | 0 | 0 | |
Temporary equity shares outstanding | 30,000,000 | 30,000,000 | |
Percentage of total shares issued and outstanding after conversion from one class to another | 20.00% | ||
Common Class B [Member] | |||
Class of Stock [Line Items] | |||
Common stock par or stated value per share | $ 0.0001 | $ 0.0001 | |
Common stock shares authorized | 20,000,000 | 20,000,000 | |
Common stock shares issued | 7,503,750 | 7,500,000 | 7,500,000 |
Common stock shares outstanding | 7,500,000 | 7,500,000 | |
Common Class B [Member] | Over-Allotment Option [Member] | |||
Class of Stock [Line Items] | |||
Founders shares included aggregate subject to forfeiture | 978,750 | ||
Underwriters partially exercised subject to forfeiture | 975,000 | ||
Common Class B [Member] | Proposed Public Offering [Member] | |||
Class of Stock [Line Items] | |||
Common stock shares issued | 7,503,750 | ||
Common stock shares outstanding | 7,503,750 | 7,503,750 | |
Common Class B [Member] | Sponsor [Member] | |||
Class of Stock [Line Items] | |||
Share based compensation by share based payment arrangement shares forfeited | 3,750 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) - USD ($) | May 02, 2022 | Apr. 26, 2022 | Feb. 01, 2022 | Jan. 18, 2022 | Nov. 16, 2021 | Mar. 31, 2022 | Mar. 31, 2021 |
Subsequent Event [Line Items] | |||||||
Advances from Sponsor | $ 350,000 | $ 0 | |||||
Sponsor [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Advances from Sponsor | $ 250,000 | $ 100,000 | $ 100,000 | ||||
Advances From Related Party [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Advances from Sponsor | $ 250,000 | $ 100,000 | $ 100,000 | ||||
Subsequent Event [Member] | Advances From Related Party [Member] | Sponsor [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Advances from Sponsor | $ 100,000 | $ 50,000 |